drugset / Trial / NCT02145884

Topical Timolol Gel for the Treatment of Infantile Hemangiomas

NCT02145884

NaSingle-groupOpen-labelTreatment

Summary

We plan to conduct a study, to see how safe and effective timolol maleate 0.5% gel-forming solution is for infantile hemangiomas (IH) and the response of hemangiomas to timolol maleate 0.5% . Our hypothesis is that timolol will inhibit and possibly reverse growth of appropriate infantile hemangiomas.

Timeline

Start
2014-05
Primary completion
2016-10
Completion
2016-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Timolol Other / unclassified 0.5 % Topical

Indications